Assura (AGR) Share Price, News & Analysis

Company Overview

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served. We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.

Key Stats

• Today's Range: 46.76 to 48.50
• 50-Day Range: 47.48 to 47.48
• 52-Week Range: 35.24 to 50.95
• Volume: 288,991 shs
• Average Volume: 25.00 million shs
• Market Capitalization: £1.54 billion
• P/E Ratio: 895.85
• Dividend Yield: 7.10%
• Price Target: GBX 60
• Consensus Rating: Moderate Buy

Assura Stock Analysis - MarketRank™

Assura scored higher than 40% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Assura has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

Upside Potential

Assura has a consensus price target of GBX 60, representing about 26.4% upside from its current price of GBX 47.48.

Amount of Analyst Coverage

Assura has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Assura is 895.85, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.57.

Price to Earnings Ratio vs. Sector

The P/E ratio of Assura is 895.85, which means that it is trading at a more expensive P/E ratio than the Real Estate sector average P/E ratio of about 29.21.

Price to Earnings Growth Ratio

Assura has a PEG Ratio of 3.60. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Assura has a P/B Ratio of 0.89. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for AGR.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Assura is a leading dividend payer. It pays a dividend yield of 7.10%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Assura does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Assura is 63.40%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Assura this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Assura insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.93% of the stock of Assura is held by insiders.

Percentage Held by Institutions

67.16% of the stock of Assura is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/21/2025
• Today: 5/21/2026

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Real Estate
• Industry: REIT - Healthcare Facilities
• Sub-Industry: Utilities
• Current Symbol: LON:AGR
• CIK: N/A
• Web: www.assuraplc.com
• Phone: +44-1925-420660
• Fax: N/A
• Employees: 84
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Assura: GBX 60
• High Price Target: GBX 60
• Low Price Target: GBX 60
• Potential Upside/Downside: +26.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 0.05
• Trailing P/E Ratio: 895.85
• Forward P/E Ratio: 13.25
• P/E Growth: 3.6
• Net Income: -£34.15 million
• Net Margins: 90.32%
• Pretax Margin: N/A
• Return on Equity: 10.66%
• Return on Assets: 2.82%

Debt

• Debt-to-Equity Ratio: 94.06
• Current Ratio: 0.73
• Quick Ratio: 2.84

Sales & Book Value

• Annual Sales: £183.80 million
• Price / Sales: 8.39
• Cash Flow: GBX 4.78 per share
• Price / Cash Flow: 9.93
• Book Value: GBX 53.62 per share
• Price / Book: 0.89

Miscellaneous

• Outstanding Shares: 3,249,640,000
• Free Float: N/A
• Market Cap: £1.54 billion
• Optionable: Not Optionable
• Beta: 0.37